Dr. Galarza Fortuna completed her Hematology-Oncology fellowship at the University of Utah, where she served as Chief Fellow. Her clinical and research focus is on plasma cell disorders, including multiple myeloma and amyloidosis, with an emphasis on novel therapies such as immunotherapies and CAR-T cell therapy. She specializes in the care of patients with multiple myeloma, amyloidosis, Waldenstrom's macroglobulinemia, and related conditions.